A panel of experts discuss the complex nature of myelodysplastic syndromes and concurrent subclassifications. At the start, we’re going to lean heavily on Dr Zeidan because we want to have a good ...

How are myelodysplastic syndromes diagnosed and staged? What causes them? An expert from Moffit Cancer Center offers insight. Myelodysplastic syndromes, known commonly as MDS, are a group of bone ...

Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, ...

Myelodysplastic syndromes (MDS) are blood cancers caused by an insufficient production of healthy blood cells. Production of irregular cells leads to anemia, where the body’s organs and tissues don’t ...

Myelodysplastic syndrome (MDS) refers to a group of blood and bone marrow cancers. It develops when a person has low levels of certain types of blood cell in their body. Healthcare professionals used ...

Myelodysplastic syndromes (MDS) are blood cancers where bone marrow makes too few healthy blood cells. Many of the cells produced die early or do not function normally. Early myelodysplastic syndromes ...

Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with ...

Myelodysplastic syndromes (MDS) are a group of disorders in which a person’s bone marrow does not produce enough functioning blood cells. MDS is a type of cancer that damages some of the blood-forming ...

MDS occur mainly, but not exclusively, in patients with a median age of about 70 years, and the crude incidence is 4 to 5 cases per 100,000 persons per year. 8 The true incidence is likely to be ...